Silence Therapeutics plc announced the appointment of Stuart Collinson as Non-Executive Director of the company, with immediate effect. Silence also announced the resignation of Simon Sturge as Non-Executive Director of the company, with immediate effect. Simon has decided to resign from the Board due to his other business commitments.

Stuart will take on the role of Chair the Remuneration Committee. Dr. Collinson has held executive and senior management positions in public and private life science companies in the US and Europe. Dr. Collinson is a partner of Forward Ventures, a biopharmaceutical venture capital fund, Chairman and CEO of Tioga Pharmaceuticals Inc., and Director of Arcturus Therapeutics Inc. and Essentialis Inc.